SUHEUNG CO.,LTD. Logo

SUHEUNG CO.,LTD.

Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.

008490 | KO

Overview

Corporate Details

ISIN(s):
KR7008490005
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명로 61 -, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Suheung Co., Ltd. is a global manufacturer specializing in capsules for the pharmaceutical and nutraceutical industries. Established in 1973, the company produces a wide range of empty hard and soft capsules, as well as other solid dosage forms like tablets. Suheung is a vertically integrated enterprise, offering comprehensive contract manufacturing services that cover the entire process from raw material supply to final packaging. As one of the largest capsule suppliers worldwide, the company serves major global markets, emphasizing quality and continuous research and development to deliver solutions for its clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 83.3 KB
2025-08-14 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 5.1 MB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 5.0 MB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 1.0 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 3.0 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 712.2 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 20.8 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 17.8 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 62.1 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.1 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 373.7 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.4 KB
2025-02-18 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 13.9 KB
2025-02-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.5 KB

Automate Your Workflow. Get a real-time feed of all SUHEUNG CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SUHEUNG CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SUHEUNG CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.